Free Trial

Cognex (NASDAQ:CGNX) Price Target Cut to $70.00 by Analysts at Stephens

Cognex logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Stephens cut Cognex’s price target from $85 to $70 but maintained an Overweight rating; the new target implies 46.98% upside from the prior close.
  • Analyst views remain mixed but lean positive: Cognex has a consensus “Moderate Buy” rating and an average price target of $72.93, despite recent target reductions from several firms.
  • Cognex reported quarterly EPS of $0.53, slightly above estimates, while revenue of $313.39 million narrowly missed expectations; revenue rose 13% year over year.
  • MarketBeat previews the top five stocks to own by December 1st.

Cognex (NASDAQ:CGNX - Get Free Report) had its price target dropped by research analysts at Stephens from $85.00 to $70.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has an "overweight" rating on the scientific and technical instruments company's stock. Stephens's price target indicates a potential upside of 46.98% from the stock's previous close.

Other research analysts have also recently issued research reports about the company. KeyCorp cut their price target on Cognex from $80.00 to $65.00 and set an "overweight" rating on the stock in a research note on Friday. Wall Street Zen downgraded Cognex from a "buy" rating to a "hold" rating in a report on Sunday, September 13th. Truist Financial dropped their price objective on Cognex from $74.00 to $57.00 and set a "hold" rating on the stock in a report on Friday. Weiss Ratings raised Cognex from a "hold (c)" rating to a "hold (c+)" rating in a research report on Tuesday, August 11th. Finally, Cantor Fitzgerald increased their target price on Cognex from $76.00 to $84.00 and gave the company an "overweight" rating in a research note on Friday, August 7th. One research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have issued a Hold rating to the company. Based on data from MarketBeat, Cognex currently has a consensus rating of "Moderate Buy" and a consensus price target of $72.93.

Get Our Latest Stock Report on Cognex

Cognex Price Performance

CGNX stock traded up $0.14 during trading on Friday, reaching $47.63. 2,758,338 shares of the stock traded hands, compared to its average volume of 2,131,928. The business's 50 day moving average price is $59.36 and its 200-day moving average price is $57.99. Cognex has a 52-week low of $34.60 and a 52-week high of $72.88. The firm has a market capitalization of $8.01 billion, a PE ratio of 33.22 and a beta of 1.49.

Cognex (NASDAQ:CGNX - Get Free Report) last released its quarterly earnings data on Wednesday, November 4th. The scientific and technical instruments company reported $0.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.52 by $0.01. The company had revenue of $313.39 million during the quarter, compared to analyst estimates of $313.62 million. Cognex had a net margin of 21.50% and a return on equity of 16.24%. The business's quarterly revenue was up 13.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.33 earnings per share. On average, equities research analysts predict that Cognex will post 1.68 earnings per share for the current year.

Institutional Investors Weigh In On Cognex

Several institutional investors have recently bought and sold shares of CGNX. IFP Advisors Inc lifted its stake in shares of Cognex by 21.6% in the 2nd quarter. IFP Advisors Inc now owns 956 shares of the scientific and technical instruments company's stock valued at $69,000 after purchasing an additional 170 shares during the period. State of Michigan Retirement System grew its stake in shares of Cognex by 0.5% during the first quarter. State of Michigan Retirement System now owns 39,853 shares of the scientific and technical instruments company's stock worth $1,952,000 after purchasing an additional 200 shares during the period. Mather Group LLC. increased its holdings in Cognex by 81.3% in the third quarter. Mather Group LLC. now owns 446 shares of the scientific and technical instruments company's stock valued at $27,000 after purchasing an additional 200 shares during the last quarter. SYM FINANCIAL Corp increased its holdings in Cognex by 6.3% in the third quarter. SYM FINANCIAL Corp now owns 3,372 shares of the scientific and technical instruments company's stock valued at $204,000 after purchasing an additional 201 shares during the last quarter. Finally, Eastern Bank lifted its stake in Cognex by 20.0% in the third quarter. Eastern Bank now owns 1,242 shares of the scientific and technical instruments company's stock valued at $75,000 after buying an additional 207 shares during the period. Institutional investors and hedge funds own 88.12% of the company's stock.

Cognex News Roundup

Here are the key news stories impacting Cognex this week:

  • Positive Sentiment: Cognex reported record Q3 results: adjusted EPS of $0.53 beat estimates, and revenue rose 13% year over year to $313.4 million. Management raised its 2026 revenue outlook to $1.14 billion–$1.16 billion and cited margin-expansion opportunities, stronger logistics demand, and potential growth from its planned RealSense acquisition. Q3 earnings call highlights
  • Positive Sentiment: The company raised its quarterly dividend 5.9% to $0.09 per share, signaling a modest increase in shareholder returns. Dividend announcement
  • Negative Sentiment: Truist cut its price target to $57 and maintained a Hold rating; KeyCorp lowered its target to $65 but retained Overweight, and Needham reduced its target to $70 while keeping Buy. The repeated target reductions may weigh on sentiment, though all three targets remain above the stock’s recent price. Truist rating information

Cognex Company Profile

(Get Free Report)

Cognex Corporation develops machine vision and industrial identification technologies that help manufacturers and businesses automate inspection, measurement, guidance, and tracking processes. Its systems use cameras, sensors, software, and artificial intelligence to analyze images and identify products, defects, components, and other objects.

The company's product portfolio includes vision systems, industrial cameras, vision sensors, barcode readers, optical character recognition tools, three-dimensional vision systems, and machine vision software.

Recommended Stories

Analyst Recommendations for Cognex (NASDAQ:CGNX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Cognex Right Now?

Before you consider Cognex, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cognex wasn't on the list.

While Cognex currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Oil still powers the global economy, but AI is reshaping the energy opportunity. Discover seven stocks spanning traditional energy, infrastructure, and next-generation power.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines